Causes of DNA mismatch repair deficiency in sebaceous skin lesions demonstrating loss of MLH1 protein expression: constitutional over somatic MLH1 promoter methylation.
Journal: Familial cancer
Year: January 21, 2025
Geneticist
4.5
No OPD information available
Familial Colorectal Cancer
Lynch Syndrome
Colorectal Cancer
Turcot Syndrome
Endometrial Cancer
Familial Adenomatous Polyposis
Brain Tumor
Colonoscopy
Mosaicism
Sebaceous Adenoma
Mark Clendenning is a male healthcare provider who helps patients with different health conditions like Familial Colorectal Cancer, Lynch Syndrome, Colorectal Cancer, and more. He also performs procedures like colonoscopies and treats brain tumors.
Mark Clendenning uses his special skills to diagnose and treat patients with various genetic conditions. He is known for his expertise in identifying and managing conditions like Familial Adenomatous Polyposis and Turcot Syndrome.
Patients trust Mark Clendenning because he communicates clearly and compassionately. He takes the time to explain medical information in a way that is easy to understand, making patients feel comfortable and well-informed about their health.
To stay updated with the latest medical knowledge, Mark Clendenning regularly attends conferences, reads research papers, and collaborates with other healthcare professionals. This ensures that he can provide the best possible care to his patients.
Mark Clendenning works closely with his colleagues, sharing knowledge and expertise to improve patient outcomes. He values teamwork and believes in a collaborative approach to healthcare, where different specialists work together for the benefit of the patient.
Mark Clendenning's dedication to his work has had a positive impact on many patients' lives. Through his research and clinical practice, he has helped improve the health and well-being of individuals with genetic conditions and cancer.
One of Mark Clendenning's notable publications is "Causes of DNA mismatch repair deficiency in sebaceous skin lesions demonstrating loss of MLH1 protein expression: constitutional over somatic MLH1 promoter methylation." This research article, published in Familial Cancer, highlights his contributions to the field of genetics and cancer research.
In summary, Mark Clendenning is a skilled and compassionate healthcare provider who is dedicated to improving the lives of his patients through his expertise, communication skills, and commitment to staying updated with the latest medical knowledge.
Journal: Familial cancer
Year: January 21, 2025
Mark Clendenning is a fantastic Geneticist. He explained everything clearly and made me feel at ease during my consultation. Highly recommend!
I had a great experience with Mark Clendenning. He was very knowledgeable and caring. I felt confident in his expertise as a Geneticist.
Mark Clendenning is a wonderful Geneticist. He took the time to listen to my concerns and provided thorough explanations. I left feeling reassured and informed.
I am grateful for the care I received from Mark Clendenning. He is a skilled Geneticist who genuinely cares about his patients' well-being. Highly satisfied with my visit.
Mark Clendenning is an excellent Geneticist. He was patient, kind, and answered all my questions in a way that was easy to understand. I felt comfortable throughout the appointment.
I had a positive experience with Mark Clendenning as my Geneticist. He was professional, thorough, and made me feel like my health was a top priority. Highly recommend him!
Mark Clendenning is a top-notch Geneticist. He was attentive, knowledgeable, and made me feel heard. I left the appointment feeling confident in his expertise.